Caxton

Latest statistics and disclosures from Caxton Corp's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are GLD, BRK.B, KYTX, LXEO, XFOR, and represent 97.77% of Caxton Corp's stock portfolio.
  • Added to shares of these 3 stocks: GLD, ALXO, BRK.B.
  • Started 1 new stock position in ALXO.
  • Reduced shares in these 5 stocks: SYRE, MNMD, CMPX, SABS, CNTX.
  • Sold out of its positions in SYRE, CMPX, CNTX, MNMD, SABS.
  • Caxton Corp was a net seller of stock by $-393k.
  • Caxton Corp has $4.0M in assets under management (AUM), dropping by -5.96%.
  • Central Index Key (CIK): 0001388551

Tip: Access up to 7 years of quarterly data

Positions held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Caxton Corp

Caxton Corp holds 7 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Gold Tr Gold Shs (GLD) 81.5 $3.3M +9% 7.6k 430.27
 View chart
Berkshire Hathaway Inc Del Cl B New (BRK.B) 8.7 $348k +2% 727.00 479.15
 View chart
Kyverna Therapeutics (KYTX) 4.0 $162k 19k 8.63
 View chart
Lexeo Therapeutics (LXEO) 2.0 $80k 14k 5.74
 View chart
X4 Pharmaceuticals Com New (XFOR) 1.6 $64k 16k 4.13
 View chart
Inhibikase Therapeutics Com New (IKT) 1.2 $48k 29k 1.68
 View chart
Alx Oncology Hldgs (ALXO) 1.0 $42k NEW 21k 2.00
 View chart

Past Filings by Caxton Corp

SEC 13F filings are viewable for Caxton Corp going back to 2013

View all past filings